Enzymatic omega-oxidation and omega-amination of fatty acids
View Patent ↗The invention relates to a method for oxidizing a fatty acid or an ester thereof of formula (I) H3C —(CH2)n-COOR, wherein R is selected from the group that comprises H, methyl, ethyl, propyl, and butyl, wherein n is 0 to 30, preferably 6 to 24, comprising the step of oxidizing the fatty acid or the ester thereof by contacting the fatty acid or the ester thereof with a cytochrome P450 monooxygenase of the CYP153 family in the presence of molecular oxygen and NAD(P)H and a whole-cell catalyst that expresses a recombinant cytochrome P450 monooxygenase of the CYP153 family, a recombinant alcohol dehydrogenase, a recombinant transaminase, and optionally one or more than one recombinant enzyme from the group comprising alanine dehydrogenase, ferredoxin, and ferredoxin reductase, and the use of said whole-cell catalyst to oxidize a fatty acid or an ester thereof.
1. A method for oxidizing a fatty acid or an ester of the formula (I):
H 3 C—(CH 2 ) n —COOR (I),
where R is H, methyl, ethyl, propyl or butyl, and n is an integer from 6 to 30,
the method comprising:
a) contacting the fatty acid or the ester with a cytochrome P450 monooxygenase of the CYP153 family in the presence of molecular oxygen, NAD(P)H, and an electron donor, such that the fatty acid or the ester is oxidized and at least one fatty acid alcohol is produced, wherein the cytochrome P450 monooxygenase of the CYP153 family comprises a peptide having the amino acid sequence of SEQ ID NO: 21;
b) contacting the fatty acid alcohol produced in a) with an alcohol dehydrogenase, such that the fatty acid alcohol reacts with the alcohol dehydrogenase, and aldehyde or ketone is produced; and
c) contacting the aldehyde or ketone produced in b) with a transaminase in the presence of an amine donor, such that the aldehyde or ketone is aminated,
wherein the contacting in a), b), and c) occurs in the presence of a cell which is genetically transformed to have a vector having a gene encoding the cytochrome P450 monooxygenase of the CYP153 family and at least one additional gene selected from the group consisting of a gene encoding the alcohol dehydrogenase and a gene encoding the transaminase, such that the cell expresses the cytochrome P450 monooxygenase of the CYP153 family, and at least one of the alcohol dehydrogenase and the transaminase.
2. The method according to claim 1 , wherein the alcohol dehydrogenase is selected from the group consisting of
a NAD(P) + -dependent alcohol dehydrogenase,
an alcohol dehydrogenase from Pseudomonas putida comprising the amino acid sequence of SEQ ID NO: 46 or a variant thereof, wherein the variant of the alcohol dehydrogenase from Pseudomonas putida has at least 70% homology to the amino acid sequence of SEQ ID NO: 46,
a flavin-containing alcohol dehydrogenase from Candida tropicalis comprising the amino acid sequence of SEQ ID NO: 40 or a variant thereof, wherein the variant of the flavin-containing alcohol dehydrogenase from Candida tropicalis has at least 70% homology to the amino acid sequence of SEQ ID NO: 40, and
a flavin-containing alcohol dehydrogenase from Candida cloacae comprising the amino acid sequence of SEQ ID NO: 68 or a variant thereof, wherein the variant of the flavin-containing alcohol dehydrogenase from Candida cloacae has at least 70% homology to the amino acid sequence of SEQ ID NO: 68.
3. The method according claim 1 , wherein the electron donor is at least one of a ferredoxin reductase and a ferredoxin.
4. The method according to claim 1 ,
wherein the contacting in c) is carried out in the presence of an alanine dehydrogenase, ammonia, and NADH, and
the alanine dehydrogenase is an alanine dehydrogenase from Bacillus subtilis subsp. subtilis str. 168 having the amino acid sequence of SEQ ID NO: 22 or an alanine dehydrogenase having an amino acid sequence having at least 70% homology to the amino acid sequence of SEQ ID NO: 22.
5. The method according to claim 1 ,
wherein the electron donor is at least one of a ferredoxin reductase and a ferredoxin, and
the contacting in c) is carried out in the presence of an alanine dehydrogenase, ammonia, and NAD(P)H.
6. The method according to claim 5 , wherein the vector further has a gene encoding the ferredoxin reductase, a gene encoding the ferredoxin, or both, such that the cell further expresses the ferredoxin reductase, the ferredoxin, or both.
7. The method according to claim 1 , wherein the cell further expresses an AlkL polypeptide having the amino acid sequence of SEQ ID NO: 1, SEQ NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ NO: 9, or SEQ ID NO: 11.
8. The method according to claim 1 ,
wherein the cell has a reduced activity of an enzyme which catalyzes at least one reaction of β-oxidation of a fatty acid, compared to an activity in a corresponding wildtype cell, and
the enzyme is at least one selected from the group consisting of FadA, FadB, FadD, FadL, and FadE from Escherichia coli.
9. The method according to claim 1 , wherein the contacting in c) is carried out in the presence of an alanine dehydrogenase, ammonia, and NAD(P)H.
10. The method according to claim 1 , wherein the cytochrome P450 monooxygenase of the CYP153 family has a peptide having the amino acid sequence of SEQ ID NO: 19 or a peptide having an amino sequence having 90% or more of homology to the amino acid sequence of SEQ ID NO: 19.
11. The method according to claim 10 , wherein the fatty acid or the ester comprises methyl laurate.
12. The method according to claim 10 ,
wherein the fatty acid or the ester comprises methyl laurate, and
the electron donor is at least one of a ferredoxin reductase and a ferredoxin.